Evidence-Based Pharmacogenomics to Help Improve Care and Lower Costs Across 13 States

June 18, 2024 – Houston, TX and Baton Rouge, LA –  The Physician’s Accountable Care Organization (TP-ACO), today announced that it has selected YouScript, an Aranscia company, to power an organization-wide personalized medication management program.  The award-winning YouScript platform helps to proactively identify and mitigate costly and potentially dangerous medication issues, and incorporates insights from pharmacogenomic (PGx) testing and other comprehensive precision prescribing information into the clinical workflow.  Under this multi-year agreement, the YouScript performance platform will be fully at risk with TP-ACO.

The science of pharmacogenomics helps to identify and mitigate potential risks associated with an individual’s unique response to a medication, and the results of a PGx test can be used by ordering providers to help identify safer and more effective therapies.  Optimizing patient medications with PGx, in conjunction with standard medication management initiatives, can help to reduce risks from unwanted side effects, adverse events, medication adherence, and prescribing cascade.  Supporting precision care programs like PGx affirms TPA-ACO’s ongoing commitment to innovation that delivers value and helps to reduce the challenges from one-size-fits-all prescribing that make Adverse Drug Events (ADEs) the 4^th leading cause of preventable death in the United States.

Starting today, all TP-ACO participating systems and providers in 13 states can access to the YouScript platform to help assess patients for potential medication risks, facilitate PGx testing, and obtain clinical insights.  YouScript’s performance support team includes clinical and pharmacy resources to assist TP-ACO providers, helping to maximize the overall care and cost savings afforded by the program for the benefit of TP-ACO.

“On behalf of our entire team, we are thrilled to embark on this partnership with TP-ACO,” said Kristine Ashcraft, Founder and President of YouScript.  “Our platform has already demonstrated the promise, power, and ROI from personalized medication management when incorporated strategically across a care population, and we are confident that TP-ACO’s commitment to our process will enable it to expand upon our success in real-world pharmacogenomics programs,” added Ashcraft.

“YouScript’s proprietary methodologies for risk assessment, demonstrated programmatic ROI, and intuitive multi-factor approach to medication management, make it the ideal partner for TP-ACO,” said John Woods, Chief Executive Officer and Chief Financial Officer, TP-ACO.  “YouScript’s confidence in the program’s performance, supported by the industry’s largest body of published research, further supports our mission at TP-ACO to bring best-in-class approaches to care improvement and cost efficiency,” added Woods.

TP-ACO members who wish to engage with YouScript can contact [email protected].  For more information about joining TP-ACO, please contact [email protected].

###

About YouScript: YouScript is a leader in pharmacogenomics research, insights, and software solutions that help make precision prescribing possible. YouScript’s lab-agnostic PGx risk, insights, and reference solutions assist clinical professionals to make fast, proactive decisions at the point of care. YouScript’s PGx program support and research initiatives span more than two decades, and have often served as a foundational basis for best practices in assessing categorial risk and measuring outcomes across the entire PGx industry. For more information, please visit www.youscript.com.

About The Physician’s Accountable Care Organization (TP-ACO): About The Physician’s Accountable Care Organization (TP-ACO):  Founded in 2012, TP-ACO is a leading ACO supporting physician-led organizations to manage risks and generate shared savings, save money for CMS and supporting continued high-quality of care to its attributed patients.  TP-ACO is an ‘Enhanced Track’ full-risk Accountable Care Organization under the MSSP and currently operates in 13 states.  For more information, please visit www.tpacsecure.com.

Media Contact:
Karina Stabile
516-317-5835
[email protected]

Read the source press release on PRNewswire.

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies

SEATTLE, WA – May 9, 2024 – YouScript, an Aranscia company, today announced that it has been selected as winner of the “Genomics Innovation Award” in the 8^th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market.

YouScript’s pharmacogenomics (PGx) software and solutions enable healthcare providers and organizations to build, deliver, and scale comprehensive personalized medication management programs. Through decades of industry leadership, program execution, and outcomes analytics, YouScript helps providers identify, mitigate, and demonstrate the clinical value of incorporating both drug-drug and multi-drug-gene interactions as part of their care workflows.

Incorporating YouScript as part of a proactive personalized medication management program has been shown to help providers mitigate the potential for dangerous adverse drug events, including associated hospital and emergency department visits. Providers can easily assess the potential impact of PGx insights on a patient population through YouScript’s categorical risk framework, optimizing equitable patient care across all demographics. The company’s team of clinical pharmacists works to continually ensure that new pharmaceutical innovations and guidelines are available to clinical program leaders so they can maximize high-evidence insights.

“We’re honored to receive the ‘Genomics Innovation Award’ from MedTech Breakthrough and bring further awareness to our mission of helping providers improve patient safety and care,” said Kristine Ashcraft, Founder and President, YouScript. “Pharmacogenomics is a foundational element of precision medicine, enabling a healthier future for all and helping to save lives and reduce costs through the prevention and mitigation of avoidable adverse drug events. YouScript will continue to lead the industry in developing innovative solutions that assist providers in assessing high-quality evidence on the safest and most effective drugs and doses for their patients, including multi-drug gene interactions often missed by other approaches.  We remain committed to continued advancements that help turn the tide on the plight of adverse drug events, which currently claim an American life every two minutes,” added Ashcraft.

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work, and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.

“YouScript’s innovation and clinical impact help healthcare providers reduce trial-and-error prescribing expenditures and improve patient outcomes. Many patients, especially the elderly or those suffering from multiple chronic diseases in disadvantaged populations, typically lack the resources to mitigate failed drug therapies and struggle with the demands of repeated clinic visits to receive new prescriptions,” said Steve Johansson, managing director, MedTech Breakthrough. “YouScript’s patented and intuitive approach to bringing real-time precision and analytics to the point of prescribing has been shown to reduce healthcare costs, improve care, and also result in high provider and patient satisfaction.”

The YouScript platform’s features include detailed high-evidence information on pharmacodynamic and pharmacokinetic effects of medications, a comprehensive database of drug interaction, genotype-based drug and dosage recommendations, and an “Alternatives Selector” that assists providers with a schedule of medications based on individual genetic profiles and drug regimens. YouScript’s solutions can be seamlessly integrated into many leading electronic health record platforms and pharmacy software systems, and are also available to licensed providers through a desktop and mobile-friendly interface.

Ashcraft and other YouScript leaders will present an overview of PGx and its ability to optimize treatment pathways on May 15 at 1 p.m. ET. Register here to learn more about this critical aspect of healthcare.

####

About YouScript

YouScript is a leader in pharmacogenomics research, insights, and software solutions that help make precision prescribing possible. YouScript’s lab-agnostic PGx risk, insights, and reference solutions assist clinical professionals to make fast, proactive decisions at the point of care. YouScript’s PGx program support and research initiatives span more than two decades and have often served as a foundational basis for best practices in assessing categorial risk and measuring outcomes across the entire PGx industry. For more information, please visit www.youscript.com

About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Media Contact
Karina Stabile
Aria Marketing for Aranscia
[email protected]